| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | -0.067 | 0.1 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.049 | 0.1 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | 0.049 | 0.1 |
| mRNA | XMD8-92 | GDSC1000 | pan-cancer | AAC | -0.074 | 0.1 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |